Menu icon
A vertical stack of three evenly spaced horizontal lines.
Insider logo
The word "Insider".
Markets Insider logo
The word "Markets Insider".
Search markets
Search icon
A magnifying glass. It indicates, "Click to perform a search".
0
My Watchlist
Markets
Stocks
Indices
Commodities
Cryptocurrencies
Currencies
ETFs
News
Calendar icon
An icon in the shape of a calendar.
Economic
Earnings
Search markets
Search icon
A magnifying glass. It indicates, "Click to perform a search".
Search icon
A magnifying glass. It indicates, "Click to perform a search".
Markets Insider logo
The word "Markets Insider".
Close icon
Two crossed lines that form an 'X'. It indicates a way to close an interaction, or dismiss a notification.
Markets
The word Markets
Bonds
Funds
Pre-Market
Market Movers
Dow Jones Live
Your Portfolio
Stocks
The word Stocks
Stocks Finder
Market Movers
Index Constituents
Earnings Calendar
Dividends
Indices
The word Indices
Market Movers
Index Constituents
Dow Jones Live
S&P 500 Live
Nasdaq Live
World Map
Commodities
The word Commodities
News
Commodities Live
Gold
Oil
Copper
Cryptocurrencies
The word Cryptocurrencies
Bitcoin
Ethereum
Cryptocurrencies Live
Currencies
The word Currencies
News
Currencies Live
Currency Converter
EUR/USD
GBP/USD
US Dollar Index
ETFs
The word ETFs
News
ETF Finder
ETF Issuers
News
The word News
My Watchlist
Facebook Icon
The letter F.
Twitter icon
A stylized bird with an open mouth, tweeting.
LinkedIn icon
The word "in".
YouTube icon
A play button in the shape of a television screen.
Instagram icon
A stylized camera.
Insider logo
The word "Insider".
© 2023
Insider Inc. and
finanzen.net
GmbH (Imprint). All rights reserved.
Registration on or use of this site constitutes acceptance of our
Terms of Service
and
Privacy Policy.
Disclaimer
Accessibility
Commerce Policy
Advertising Policies
Made in NYC
Stock quotes by
finanzen.net
News for Osmotica Pharmaceuticals PLC Registered Shs
Markets Insider Automation
12h
What Wall Street expects from Osmotica Pharmaceuticals's earnings
Seeking Alpha
9d
Cara, Iovance, and Karyopharm among biotechs with no exposure to SVB (updated)
Seeking Alpha
70d
RVL Pharmaceuticals stock soars after sees Q4 net sales of UPNEEQ about $12.1M, up 21% Q/Q
TipRanks
129d
Analysts Are Bullish on These Healthcare Stocks: Kezar Life Sciences (KZR), RVL Pharmaceuticals (RVLP)
GlobeNewswire
129d
RVL Pharmaceuticals plc Reports Third Quarter 2022 Financial Results; Provides Commercial Update
Seeking Alpha
129d
RVL Pharmaceuticals plc GAAP EPS of -$0.16 in-line, revenue of $10.02M in-line
GlobeNewswire
136d
RVL Pharmaceuticals plc to Discuss Third Quarter 2022 Financial Results and Provide Commercial Update
Benzinga
146d
Netflix To Rally Around 17%? Plus This Analyst Predicts $144 For Electronic Arts
InvestorPlace
152d
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
TipRanks
152d
Analysts Are Bullish on These Healthcare Stocks: Synlogic (SYBX), RVL Pharmaceuticals (RVLP)
Seeking Alpha
153d
Akouos, AVEO lead healthcare gainers; Salarius, RVL among losers
GlobeNewswire
153d
RVL Pharmaceuticals plc Announces Preliminary Third Quarter 2022 UPNEEQ® Net Product Sales
Seeking Alpha
153d
RVL Pharmaceuticals sees Q3 net sales of UPNEEQ for eye treatment about $10M
Benzinga
175d
Why Golden Ocean Group Is Trading Higher By 7%; Here Are 28 Stocks Moving Premarket
Seeking Alpha
177d
MULN, REE and RVLP are among mid-day gainers and losers
Seeking Alpha
180d
IONS,ZI and PERI are among after hour movers
Benzinga
186d
Why Vintage Wine Estates Shares Tumbled 40%; Here Are 70 Biggest Movers From Yesterday
Benzinga
186d
Why SciSparc Is Trading Higher By 68%, Here Are 48 Stocks Moving In Wednesday's Mid-Day Session
Seeking Alpha
187d
bioAffinity, NeuroOne top healthcare gainers; Altimmune, Comera lead losers' pack
Seeking Alpha
187d
MDXG, EOSE and BORR among pre market gainers
Seeking Alpha
200d
ATVI, BLDP and ARCT are among after hour movers
GlobeNewswire
201d
RVL Pharmaceuticals plc to Present at the H.C. Wainwright 24th Annual Global Investment Conference
GlobeNewswire
202d
Revision Skincare® Announces Strategic Partnership with RVL Pharmaceuticals plc
Seeking Alpha
202d
RVL Pharma in pact with Revision Skincare to broaden access to products
Benzinga
216d
This Financial Services Stock Surged Around 116%; Here Are 86 Biggest Movers From Yesterday
Benzinga
216d
Why Viridian Therapeutics Is Trading Higher By Around 58%, Here Are 67 Stocks Moving In Monday's Mid-Day Session
GlobeNewswire
221d
RVL Pharmaceuticals plc Reports Second Quarter 2022 Financial Results; Provides Commercial Update
Seeking Alpha
221d
GAAP EPS of -$0.14 beats by $0.07, revenue of $8.45M misses by $0.07M
Markets Insider Automation
222d
Here's what Wall Street expects from Osmotica Pharmaceuticals's earnings
GlobeNewswire
227d
RVL Pharmaceuticals plc Announces Insider and Athyrium-Led Financing
GlobeNewswire
228d
RVL Pharmaceuticals plc to Discuss Second Quarter 2022 Financial Results and Provide Commercial Update
InvestorPlace
244d
7 Stocks to Sell Now
Seeking Alpha
254d
ORMP, SRAX and RVLP among mid-day movers
Benzinga
255d
The Daily Biotech Pulse: Pfizer Inks Pact With Africa For COVID-19 Pills, Emergent Bio & Ridgeback To Increase Access To Ebola Treatment, ADC Therapeutics & Sobi In European Pact For Lymphoma Drug
PR Newswire
255d
RVL Pharmaceuticals plc Announces Preliminary Second Quarter 2022 UPNEEQ® Net Product Sales Results
Seeking Alpha
256d
RVL Pharma posts preliminary 42% sales growth for eye treatment
GlobeNewswire
256d
RVL Pharmaceuticals plc Announces Preliminary Second Quarter 2022 UPNEEQ® Net Product Sales Results
GlobeNewswire
276d
RVL Pharmaceuticals plc Announces Result of Proposal 3 at Annual General Meeting
GlobeNewswire
308d
RVL Pharmaceuticals plc to Present at Upcoming Conferences
GlobeNewswire
312d
RVL Pharmaceuticals plc Reports First Quarter 2022 Financial Results; Provides Commercial Update
Seeking Alpha
312d
GAAP EPS of -$0.08 beats by $0.13, revenue of $21.4M beats by $14.6M
Markets Insider Automation
313d
Osmotica Pharmaceuticals earnings preview: what to expect
PR Newswire
315d
UPNEEQ® Wins Best Professional-Treatment Product by Shape Magazine in the 2022 "Shape Healthy Skin Awards"
GlobeNewswire
318d
RVL Pharmaceuticals plc to Discuss First Quarter 2022 Financial Results and Provide Commercial Update
PR Newswire
348d
UPNEEQ® Wins "Best in Innovation" Award from New Beauty
GlobeNewswire
348d
RVL Pharmaceuticals plc Announces Preliminary First Quarter 2022 UPNEEQ® Net Product Sales Results
Seeking Alpha
348d
RVL Pharmaceuticals stock rises on preliminary Q1 sales of eye drug Upneeq
GlobeNewswire
354d
RVL Pharmaceuticals plc Reports Fourth Quarter and Full Year 2021 Financial Results; Provides Preliminary First Quarter 2022 UPNEEQ® Revenue Estimate and Business Update
Markets Insider Automation
356d
What Wall Street expects from Osmotica Pharmaceuticals's earnings
GlobeNewswire
361d
RVL Pharmaceuticals plc to Discuss Fourth Quarter and Full Year 2021 Financial Results and Provide First Quarter 2022 Update on Medical Aesthetic Launch
Page
Page
Page
1
Page
2
Page
3
Page
4
Page
5
Page
Page
Find News
News
GO
